Scientists harness new drug discovery tool to treat diabetes
London, Feb 23 Scientists have harnessed a new drug discovery tool to identify a player in our insulin secretion process, which could spur a new class of drugs to treat type-2 diabetes.
In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch.